{
  "identification": {
    "trialId": "METC 04",
    "open": true,
    "acronym": "TEDR1",
    "title": "TEDR1 Trial: A phase II trial to evaluate efficacy of specific EGFR inhibitors in lung cancer",
    "nctId": "NCT00000004",
    "phase": "2"
  },
  "generalEligibility": [
    {
      "references": [
        {
          "id": "I-1",
          "text": "Patient is â‰¥18 years of age."
        }
      ],
      "function": {
        "rule": "IS_AT_LEAST_X_YEARS_OLD",
        "parameters": [
          "18"
        ]
      }
    },
    {
      "references": [
        {
          "id": "I-2",
          "text": "Drug 1 as monotherapy is indicated for the treatment of adults with advanced lung cancer."
        }
      ],
      "function": {
        "rule": "AND",
        "parameters": [
          {
            "rule": "OR",
            "parameters": [
              {
                "rule": "HAS_LOCALLY_ADVANCED_CANCER",
                "parameters": []
              },
              {
                "rule": "HAS_METASTATIC_CANCER",
                "parameters": []
              }
            ]
          },
          {
            "rule": "HAS_PRIMARY_TUMOR_LOCATION_BELONGING_TO_ANY_DOID_TERM_X",
            "parameters": [
              "Lung cancer"
            ]
          }
        ]
      }
    },
    {
      "references": [
        {
          "id": "I-3",
          "text": "Patient has a confirmed EGFR C797S mutation"
        }
      ],
      "function": {
        "rule": "MUTATION_IN_GENE_X_OF_ANY_PROTEIN_IMPACTS_Y",
        "parameters": [
          "EGFR",
          "C797S"
        ]
      }
    }
  ],
  "cohorts": [
    {
      "metadata": {
        "cohortId": "A",
        "evaluable": true,
        "open": true,
        "slotsAvailable": true,
        "ignore": false,
        "description": "Lung cancer C797S cohort"
      },
      "eligibility": [
      ]
    }
  ]
}